Abortion services and providers in Canada in 2019: results of a national survey
RM Renner, M Ennis, D Contandriopoulos… - … Open Access Journal, 2022 - cmajopen.ca
Background: Since 2016, abortion care has undergone several important changes,
particularly related to the provision of medical abortion using mifepristone. We aimed to …
particularly related to the provision of medical abortion using mifepristone. We aimed to …
Barriers and facilitators to the implementation of first trimester medical abortion with mifepristone in the province of Québec: a qualitative investigation
Objective Mifepristone became available in Canada in January 2017, but provincial medical
policy delayed its use for medical abortion (MA) in Québec for 1 year. The objective of this …
policy delayed its use for medical abortion (MA) in Québec for 1 year. The objective of this …
Development and testing for a national survey: The Canadian Abortion Provider Survey (CAPS)
R Renner, MS Wagner, S Dunn, E Guilbert… - Journal of Obstetrics and …, 2020 - Elsevier
Objectives To create a questionnaire able to explore changes in abortion services,
workforce, and clinical practices compared to our 2012 Canadian survey, particularly in …
workforce, and clinical practices compared to our 2012 Canadian survey, particularly in …
[HTML][HTML] Second-and third-trimester medical abortion providers and services in 2019: results from the Canadian Abortion Provider Survey
R Renner, M Ennis, E Guilbert, G Roy… - Journal of Obstetrics and …, 2022 - Elsevier
Objectives Mifepristone became available in Canada in 2017. Updated national guidelines
recommend its off-label use for second/third-trimester medical abortion (STMA/TTMA) by …
recommend its off-label use for second/third-trimester medical abortion (STMA/TTMA) by …
Trends in medication abortion provision before and after the introduction of mifepristone: a study of the National Abortion Federation's Canadian member services
A Yalahow, J Doctoroff, A Mark, AM Foster - Contraception, 2020 - Elsevier
Objective We analyzed trends in medication abortion provision before and after the 2017
introduction of mifepristone in Canada. Methods We reviewed 2016–2018 abortion services …
introduction of mifepristone in Canada. Methods We reviewed 2016–2018 abortion services …
Provision of first-trimester medication abortion in 2019: Results from the Canadian abortion provider survey
M Ennis, R Renner, E Guilbert, WV Norman, H Pymar… - Contraception, 2022 - Elsevier
Abstract Objective To explore the Canadian first-trimester medication abortion (MA)
workforce and their clinical care following the introduction of mifepristone in 2017, updated …
workforce and their clinical care following the introduction of mifepristone in 2017, updated …
[HTML][HTML] Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
C Devane, RM Renner, S Munro, É Guilbert… - Pilot and feasibility …, 2019 - Springer
Background Direct primary care provision of first-trimester medical abortion could potentially
address inequitable abortion access in Canada. However, when Health Canada approved …
address inequitable abortion access in Canada. However, when Health Canada approved …
Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients
KI Vogel, KJ LaRoche, J El-Haddad, A Chaumont… - Contraception, 2016 - Elsevier
Abstract Introduction Although Canada decriminalized abortion in 1988, significant
disparities in access to services and an uneven geographic distribution of providers persists …
disparities in access to services and an uneven geographic distribution of providers persists …
Perspectives among Canadian physicians on factors influencing implementation of mifepristone medical abortion: a national qualitative study
S Munro, E Guilbert, MS Wagner… - The Annals of Family …, 2020 - Annals Family Med
PURPOSE Access to family planning health services in Canada has been historically
inadequate and inequitable. A potential solution appeared when Health Canada approved …
inadequate and inequitable. A potential solution appeared when Health Canada approved …
How did the introduction of mifepristone impact the availability of abortion care in Ottawa? A qualitative study with abortion patients
KJ LaRoche, IN Labeca-Gordon, AM Foster - Facets, 2020 - facetsjournal.com
In 2017, mifepristone and misoprostol became available for early pregnancy termination as
the combination pack Mifegymiso® in Ottawa, Ontario, Canada. We conducted 40 semi …
the combination pack Mifegymiso® in Ottawa, Ontario, Canada. We conducted 40 semi …
